Factors predicting the response to oral fluoropyrimidine drugs: A phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study)

Author：                

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.2, 2013-01, pp. : 437-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1135-1139

Spandidos Publications

Access to resources Recommend Favorite

Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection

By Tsai Wen-Sy  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 242-253

Springer Publishing Company

Access to resources Recommend Favorite

Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur

By Watanabe Masahiko   Nishida Osamu   Kunii Yasuo   Kodaira Susumu   Takahashi Takashi   Tominaga Takeshi   Hojyo Keiichi   Kato Tomoyuki   Niimoto Minoru   Kunitomo Kazufumi   Isomoto Hiroyasu   Ohashi Yasuo   Yasutomi Masayuki  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 98-106

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer

By Nishikawa Kazuhiro   Morita Satoshi   Matsui Takanori   Kobayashi Michiya   Takeuchi Yoji   Takahashi Ikuo   Sato Seiji   Miyashita Yumi   Tsuburaya Akira   Sakamoto Junichi   Kakeji Yoshihiro   Baba Hideo  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 363-369

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

By Kim Tae Won   Kang Won Ki   Chang Heung Moon   Park Joon Oh   Ryoo Baek Yeol   Ahn Jin Seok   Zang Dae Young   Lee Kyung Hee   Kang Yoon Koo   Kim Sung Rok   Kim Hoon-Kyo  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite